ClubsMakklerPROMarketsEconomic CalendarEarnings CalendarNewsMakklerAIFamous Investors
ENTRDE
Log InGet Started Free
OverviewStocksCryptoCurrenciesCommoditiesETFsOptionsEconomic CalendarEarnings CalendarGuru PortfoliosMy watchlist

Makkler App

Faster and clearer

Install
Overview/Stocks/AZR

Azora Therapeutics, Inc. AZR

NASDAQHealth TechnologyUnited States
$4.00+0.29 (+7.82%)

Market closed· Nov 6, 2026, 9:00 PM UTC· USD · Data may be delayed

Day's range
3.764.00
52-week range
1.318.75

Financial health

– / 5

Analyst view · 5 firms

Buy5 buy · 0 hold · 0 sell

Avg. target $10.75 (+168.8%)

OverviewFinancialsAnalysisEarningsTechnicalsHistorical dataNews

Prices may be delayed and are for informational purposes only - not investment advice.

Company news

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.

  • Nov 5, 2026
    Azora Therapeutics Appoints Board of Directors with Extensive Drug Development and Inflammatory Bowel Disease ExpertiseYahoo Finance
  • Oct 29, 2026
    Adial Pharmaceuticals, Inc. Announces Name Change to Azora Therapeutics, Inc. and New Executive Appointments on October 28, 2026Fintel
  • Aug 17, 2026
    Adial Posts Q2 2026 Results; Acquisition Of Azora Therapeutics Shifts Focus To UC; Stock DownRTTNews
Jun 23, 2026
Azarga Metals Shareholders Approve All Resolutions at Annual General and Special MeetingYahoo Finance
  • Jun 12, 2026
    Adial Acquires Azora With $64 Mln Private Placement; To Advance AT177 For Ulcerative ColitisRTTNews
  • Jun 11, 2026
    Top Biotech Gainers: VRXA Begins A New Chapter, ADIL Opens Wallet, PGEN, PCSA On Watch...RTTNews
  • Apr 27, 2026
    Adial Pharmaceuticals Applies For FDA Priority Voucher Program For AD04RTTNews
  • Feb 25, 2026
    Adial Pharmaceuticals (ADIL) Price Target Increased by 1,099.98% to 26.52Fintel
  • Feb 4, 2026
    Adial Pharma To Effect 1 For 25 Reverse Stock Split To Regain Nasdaq Compliance; Shares PlungeRTTNews
  • Jan 6, 2026
    Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year?Zacks
  • Sep 30, 2025
    Maxim Group Upgrades Adial Pharmaceuticals (ADIL)Fintel
  • Sep 1, 2025
    All You Need to Know About Adial Pharmaceuticals (ADIL) Rating Upgrade to BuyZacks
  • Jul 10, 2025
    Adial Pharmaceuticals (ADIL) Upgraded to Strong Buy: Here's WhyZacks
  • Jul 9, 2025
    Adial Pharmaceuticals Files Update to Provisional Patent Application for AD04, Enhancing Intellectual Property Protection through 2045Quiver Quantitative
  • Jun 26, 2025
    VOR Skyrockets On Ex-China Rights To Autoimmune Drug, ADIL To Face FDA On Jul.29, PSTV Jumps 14%RTTNews
  • Jun 25, 2025
    Adial Pharmaceuticals Signs Agreements with Cambrex and Thermo Fisher for AD04 Drug Production and FDA SubmissionQuiver Quantitative
  • Jun 17, 2025
    Adial Pharmaceuticals Prices $3.6 Mln Public Offering With Accompanying WarrantsRTTNews
  • May 15, 2025
    Adial Pharmaceuticals Reports First Quarter 2025 Business Update and Financial ResultsQuiver Quantitative
  • May 13, 2025
    Adial Pharmaceuticals Receives Development Milestone Payment from Adovate Following Phase 1 Clinical Trial Initiation for Asthma TreatmentQuiver Quantitative
  • May 2, 2025
    Adial Pharmaceuticals Announces Warrant Inducement Agreement for $2.75 Million in Gross ProceedsQuiver Quantitative

    • News alerts

    Use the bell at the top of the page to be notified when there is new AZR news.

    Overview
    Stocks
    Crypto
    Currencies
    Commodities
    ETFs
    Options
    Economic Calendar
    Earnings Calendar
    Guru Portfolios
    My watchlist
    See with MakklerPRO
    Details
    Clubs
    MakklerPRO
    Markets
    Economic Calendar
    Earnings Calendar
    News
    MakklerAI
    Famous Investors
    Log In
    Get Started Free

    The portfolio-sharing platform connecting finance analysts with an audience that wants to learn.

    Theme
    Platform
    ClubsMarketsMarkets NewsMakklerPROMakkler TokenHow It WorksBecome an Analyst
    Compare
    Makkler vs. eToroMakkler vs. SkoolMakkler vs. YouTube
    Company
    About UsContact
    Legal
    Terms of ServicePrivacy PolicyData Protection NoticeRisk DisclosurePayment Policy

    © 2026 Makkler, LLC. All rights reserved. Content on this platform does not constitute investment advice.

    ENTRDE